Systems Biology Opens New Research Pathways
Systems Biologists Are Attacking the Encrypted Messages That Would Allow Us to Predict and Change the Course of Disease
Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
- CA, 90404
- UNITED STATES
Ablexis is a biotechnology company dedicated to developing the AlivaMab Mouse, an innovative next-generation platform for the efficient discovery and development of the next wave of human therapeutic antibodies. Ablexis is commercializing the AlivaMab Mouse platform through partnering strategies that provide broad, non-exclusive access with no target or field-of-use restrictions.